News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
866,705 Results
Type
Article (87707)
Company Profile (741)
Press Release (778240)
Multimedia
Podcasts (202)
Webinars (29)
Section
Business (233103)
Career Advice (4147)
Deals (39881)
Drug Delivery (150)
Drug Development (91266)
Employer Resources (205)
FDA (18340)
Job Trends (17430)
News (397449)
Policy (39897)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3008)
Academic (1)
Accelerated approval (35)
Adcomms (31)
Allergies (145)
Alliances (56918)
ALS (176)
Alzheimer's disease (1788)
Antibody-drug conjugate (ADC) (346)
Approvals (18542)
Artificial intelligence (562)
Autoimmune disease (175)
Automation (40)
Bankruptcy (404)
Best Places to Work (12602)
BIOSECURE Act (23)
Biosimilars (209)
Biotechnology (458)
Bladder cancer (155)
Brain cancer (59)
Breast cancer (641)
Cancer (4839)
Cardiovascular disease (385)
Career advice (3570)
Career pathing (42)
CAR-T (309)
CDC (44)
Celiac Disease (2)
Cell therapy (821)
Cervical cancer (33)
Clinical research (76802)
Collaboration (1815)
Company closure (4)
Compensation (1097)
Complete response letters (71)
COVID-19 (2974)
CRISPR (97)
C-suite (866)
Cystic fibrosis (149)
Data (6141)
Decentralized trials (2)
Denatured (74)
Depression (141)
Diabetes (461)
Diagnostics (7189)
Digital health (43)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (284)
Drug pricing (195)
Drug shortages (34)
Duchenne muscular dystrophy (241)
Earnings (99803)
Editorial (62)
Employer branding (25)
Employer resources (174)
Events (134310)
Executive appointments (987)
FDA (21408)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1466)
Gene editing (210)
Generative AI (52)
Gene therapy (660)
GLP-1 (1042)
Government (5382)
Grass and pollen (8)
Guidances (378)
Healthcare (20862)
HIV (58)
Huntington's disease (50)
IgA nephropathy (85)
Immunology and inflammation (286)
Immuno-oncology (63)
Indications (109)
Infectious disease (3248)
Inflammatory bowel disease (209)
Inflation Reduction Act (16)
Influenza (124)
Intellectual property (251)
Interviews (816)
IPO (17911)
IRA (54)
Job creations (5199)
Job search strategy (2867)
JPM (70)
Kidney cancer (17)
Labor market (96)
Layoffs (650)
Leadership (39)
Legal (10137)
Liver cancer (95)
Longevity (14)
Lung cancer (660)
Lymphoma (370)
Machine learning (43)
Management (66)
Manufacturing (871)
MASH (168)
Medical device (14845)
Medtech (14894)
Mergers & acquisitions (22953)
Metabolic disorders (1280)
Multiple sclerosis (166)
NASH (22)
Neurodegenerative disease (351)
Neuropsychiatric disorders (95)
Neuroscience (3073)
Neurotech (1)
NextGen: Class of 2026 (7686)
Non-profit (5090)
Now hiring (67)
Obesity (622)
Opinion (337)
Ovarian cancer (163)
Pain (194)
Pancreatic cancer (221)
Parkinson's disease (288)
Partnered (35)
Patents (498)
Patient recruitment (487)
Peanut (60)
People (66760)
Pharmaceutical (135)
Pharmacy benefit managers (24)
Phase 1 (23754)
Phase 2 (33381)
Phase 3 (25100)
Pipeline (5355)
Policy (312)
Postmarket research (3546)
Preclinical (10663)
Press Release (72)
Prostate cancer (236)
Psychedelics (56)
Radiopharmaceuticals (297)
Rare diseases (901)
Real estate (7438)
Recruiting (81)
Regulatory (28961)
Reports (68)
Research institute (2712)
Resumes & cover letters (652)
Rett syndrome (28)
RNA editing (21)
RSV (75)
Schizophrenia (152)
Series A (253)
Series B (187)
Service/supplier (27)
Sickle cell disease (98)
Special edition (28)
Spinal muscular atrophy (175)
Sponsored (48)
Startups (4334)
State (2)
Stomach cancer (15)
Supply chain (112)
Tariffs (94)
The Weekly (126)
Vaccines (1097)
Venture capital (97)
Weight loss (422)
Women's health (84)
Worklife (22)
Date
Today (151)
Last 7 days (584)
Last 30 days (2268)
Last 365 days (29847)
2026 (3784)
2025 (30065)
2024 (36538)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1284)
Alabama (89)
Alaska (6)
Arizona (310)
Arkansas (12)
Asia (51535)
Australia (9055)
California (11105)
Canada (3193)
China (1171)
Colorado (445)
Connecticut (477)
Delaware (331)
Europe (118094)
Florida (1607)
Georgia (328)
Hawaii (4)
Idaho (67)
Illinois (910)
India (72)
Indiana (528)
Iowa (24)
Japan (435)
Kansas (135)
Kentucky (34)
Louisiana (21)
Maine (83)
Maryland (1379)
Massachusetts (8178)
Michigan (342)
Minnesota (559)
Mississippi (5)
Missouri (139)
Montana (32)
Nebraska (29)
Nevada (121)
New Hampshire (77)
New Jersey (3059)
New Mexico (33)
New York (2930)
North Carolina (1588)
North Dakota (10)
Northern California (5376)
Ohio (324)
Oklahoma (18)
Oregon (52)
Pennsylvania (2249)
Puerto Rico (25)
Rhode Island (46)
South America (1663)
South Carolina (62)
South Dakota (1)
Southern California (4292)
Tennessee (141)
Texas (1706)
United States (39797)
Utah (287)
Vermont (1)
Virginia (266)
Washington D.C. (76)
Washington State (940)
West Virginia (4)
Wisconsin (108)
Wyoming (2)
866,705 Results for "bio products laboratory ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kraig Biocraft Laboratories Activates First Wave of 2026 Production Program
February 17, 2026
·
3 min read
Press Releases
YD Bio Limited Enters into Binding Letter of Intent to Acquire Safe Save Medical Cell Sciences & Technology Co., Ltd., Bolstering Leadership in Advanced Immunocell Therapy
January 29, 2026
·
6 min read
Press Releases
SL BIO Ltd. and Horizon Space Acquisition II Corp. Announce Registration Statement Effectiveness and Extraordinary General Meeting Date to Approve Business Combination
January 15, 2026
·
8 min read
Press Releases
Cambridge Isotope Laboratories, Inc. and Chemtatva Chiral Solutions Pvt. Ltd. to Establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad, India
October 28, 2025
·
3 min read
Press Releases
Intelligent Bio Solutions Announces New Manufacturing Partnership to Strengthen Global Production Capability and Increase Margins
January 1, 2026
·
7 min read
Press Releases
LIXTE Biotechnology Appoints Sidney Braun as CEO of its Liora Technologies Europe Ltd. Subsidiary
February 18, 2026
·
5 min read
Sponsored
Taipei City Government Partners With Six Biotech Companies to Showcase at BIO International Convention 2025
The 2025 BIO International Convention (BIO2025), the world’s largest annual biotech event, will take place from June 16 to 19 (U.S. time) at the Boston Convention & Exhibition Center. This year, Taipei City Government is partnering with six Taipei-based biotech companies, including PanCAD.ai Co., Ltd., Instant NanoBiosensors Co., Ltd., Bened Biomedical Co., Ltd., Cancer Free Biotech Ltd., Xantho Biotechnology Co., Ltd., and Energenesis Biomedical Co., Ltd., to showcase their innovations at the Taiwan Pavilion (Booth #1645) in the Taipei Exhibition Area.
June 16, 2025
·
5 min read
Press Releases
Cumulus Neuroscience Enters Japanese Market to Advance Novel Cognitive Biomarkers with New Customer Shionogi & Co., Ltd.
February 10, 2026
·
4 min read
Press Releases
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency
January 19, 2026
·
4 min read
Press Releases
TempraMed Launches New Product “VIVI Med(TM),” Unlocking New Growth Opportunities in High-Value Biologics and Injectable Medications
Using same proprietary, patented technology, VIVI Med extends the product portfolio beyond injectable pens, opening access to broader patient populations, premium biologics, and institutional channel
January 23, 2026
·
6 min read
1 of 86,671
Next
